Crown ElectroKinetics Corp. (NasdaqCM : CRKN) acquired All of the assets of Amerigen, LLC for $0.65 million on January 3, 2023. Pursuant to the terms of the Asset Purchase Agreement, Amerigen sold, and the Crown ElectroKinetics acquired, all of the assets of Amerigen (other than certain excluded assets set forth in the Asset Purchase Agreement) for a purchase price of (i) $645,000 and (ii) the assumption of certain liabilities of Amerigen. In a related transaction, Crown ElectroKinetics Corp. entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain accredited investors as purchasers (the “Investors”). Pursuant to the Securities Purchase Agreement, the Company sold, and the Investors purchased, $1.2 million in principal amount of senior secured notes (the “Senior Notes”) and 2,500,000 warrants (“Warrants”), each Warrant entitling the holder to purchase one share of the Company's common stock, par value $0.0001 (“Common Stock”). Transaction is subject to the filings of Buyer and Seller pursuant to the HSR Act and have received all consents, authorizations, orders and approvals from the Governmental Authorities. Pryor Cashman LLP acted as legal advisor Marcum LLP acted as an accountant to Crown ElectroKinetics Corp.

Crown ElectroKinetics Corp. (NasdaqCM : CRKN) completed the acquisition of All of the assets of Amerigen, LLC on January 3, 2023.